Evaluation of TeleMOVE: a Telehealth Weight Reduction Intervention for Veterans with Obesity.BACKGROUND
 This observational study evaluated the efficacy of a novel home-based telehealth weight loss intervention (TeleMOVE) for Veterans with obesity.


 We obtained weight measures of 171 patients before and after one and two 90-day cycles of TeleMOVE.


 Enrollment in the first 90-day cycle of TeleMOVE was associated with significant weight loss (M = 8.62 lbs, SD = 9.85).  TeleMOVE is a promising intervention, warranting a further investigation of its efficacy.
TeleMOVE
Evaluation of TeleMOVE: a Telehealth Weight Reduction Intervention for Veterans with Obesity.BACKGROUND
 This observational study evaluated the efficacy of a novel home-based telehealth weight loss intervention (TeleMOVE) for Veterans with obesity.


 We obtained weight measures of 171 patients before and after one and two 90-day cycles of TeleMOVE.


 Enrollment in the first 90-day cycle of TeleMOVE was associated with significant weight loss (M = 8.62 lbs, SD = 9.85).  TeleMOVE is a promising intervention, warranting a further investigation of its efficacy.
TeleMOVE
Evaluation of TeleMOVE: a Telehealth Weight Reduction Intervention for Veterans with Obesity.BACKGROUND
 This observational study evaluated the efficacy of a novel home-based telehealth weight loss intervention (TeleMOVE) for Veterans with obesity.


 We obtained weight measures of 171 patients before and after one and two 90-day cycles of TeleMOVE.


 Enrollment in the first 90-day cycle of TeleMOVE was associated with significant weight loss (M = 8.62 lbs, SD = 9.85).  TeleMOVE is a promising intervention, warranting a further investigation of its efficacy.
TeleMOVE
Evaluation of TeleMOVE: a Telehealth Weight Reduction Intervention for Veterans with Obesity.BACKGROUND
 This observational study evaluated the efficacy of a novel home-based telehealth weight loss intervention (TeleMOVE) for Veterans with obesity.


 We obtained weight measures of 171 patients before and after one and two 90-day cycles of TeleMOVE.


 Enrollment in the first 90-day cycle of TeleMOVE was associated with significant weight loss (M = 8.62 lbs, SD = 9.85).  TeleMOVE is a promising intervention, warranting a further investigation of its efficacy.
TeleMOVE
Evaluation of TeleMOVE: a Telehealth Weight Reduction Intervention for Veterans with Obesity.BACKGROUND
 This observational study evaluated the efficacy of a novel home-based telehealth weight loss intervention (TeleMOVE) for Veterans with obesity.


 We obtained weight measures of 171 patients before and after one and two 90-day cycles of TeleMOVE.


 Enrollment in the first 90-day cycle of TeleMOVE was associated with significant weight loss (M = 8.62 lbs, SD = 9.85).  TeleMOVE is a promising intervention, warranting a further investigation of its efficacy.
TeleMOVE